Your browser doesn't support javascript.
loading
Cardiovascular risk prevalence in South Africans with drug-resistant tuberculosis: a cross-sectional study.
Whitehouse, E R; Perrin, N; Levitt, N; Hill, M; Farley, J E.
Afiliación
  • Whitehouse ER; Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.
  • Perrin N; Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.
  • Levitt N; Division of Diabetic Medicine and Endocrinology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Hill M; Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.
  • Farley JE; Johns Hopkins University School of Nursing, Baltimore, Maryland, USA, REACH Initiative, Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.
Int J Tuberc Lung Dis ; 23(5): 587-593, 2019 05 01.
Article en En | MEDLINE | ID: mdl-31097067
ABSTRACT
id="st1"> BACKGROUND In South Africa, the risk factors for cardiovascular disease (CVD) are increasing, thereby impacting patients with drug-resistant tuberculosis (DR-TB). id="st2"> OBJECTIVE To determine the prevalence of traditional CVD risk factors (diabetes mellitus [DM], smoking, hypertension, increased body mass index [BMI]) and a total risk score for CVD among patients with DR-TB. id="st3"> <a class="decs" id="22045">METHODS</a> This cross-sectional study was nested within an ongoing cluster-randomized trial in 10 DR-TB hospitals in South Africa. The data for the present study were collected between November 2014 and July 2016. id="st4"> RESULTS Of 900 participants aged 18 years, 75.1% were co-infected with the human immunodeficiency virus (HIV), and 52.3% had one or more CVD risk factors. The prevalence of CVD risk factors was hypertension (16.7%), increased BMI (16.6%), DM (5.2%), and smoking (31.4%). Among patients with DM or hypertension, 58.8-95.5% had additional comorbid CVD risk factors. Of 398 participants eligible for the CVD risk score (age 35 years), 23.4% had a moderate or high CVD risk score. id="st5"> CONCLUSION Patients with multiple diseases, including DR-TB and HIV, with traditional CVD risk factors, may have higher risks for negative outcomes during treatment for DR-TB. TB providers should identify people at risk to initiate primary and secondary prevention to improve outcomes. .
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Infecciones por VIH / Tuberculosis Resistente a Múltiples Medicamentos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Int J Tuberc Lung Dis Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Infecciones por VIH / Tuberculosis Resistente a Múltiples Medicamentos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Int J Tuberc Lung Dis Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos